Jefferies Financial Group Inc. Has $5.72 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Key Points

• Jefferies Financial Group Inc. increased its position in The Cooper Companies, Inc. by 39.7%, holding 67,768 shares valued at approximately $5.72 million at the end of the first quarter.
• Recent analyst reports have resulted in varied ratings for Cooper Companies, with a current consensus rating of "Moderate Buy" and a consensus target price of $96.73.
• Cooper Companies reported a quarterly EPS of $0.96, beating expectations, with revenues of $1 billion, marking a 6.3% increase year-over-year.

Jefferies Financial Group Inc. lifted its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 39.7% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 67,768 shares of the medical device company's stock after purchasing an additional 19,254 shares during the quarter. Jefferies Financial Group Inc.'s holdings in Cooper Companies were worth $5,716,000 at the end of the most recent quarter.

A number of other hedge funds have also modified their holdings of the business. City Holding Co. purchased a new position in Cooper Companies during the first quarter worth about $34,000. New Age Alpha Advisors LLC bought a new position in shares of Cooper Companies during the 4th quarter valued at about $38,000. Covestor Ltd boosted its stake in Cooper Companies by 35.5% in the 4th quarter. Covestor Ltd now owns 458 shares of the medical device company's stock worth $42,000 after purchasing an additional 120 shares during the period. Larson Financial Group LLC raised its stake in shares of Cooper Companies by 1,071.0% during the 1st quarter. Larson Financial Group LLC now owns 726 shares of the medical device company's stock worth $61,000 after purchasing an additional 664 shares in the last quarter. Finally, HM Payson & Co. raised its position in shares of Cooper Companies by 147.4% in the first quarter. HM Payson & Co. now owns 893 shares of the medical device company's stock valued at $75,000 after purchasing an additional 532 shares during the period. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have recently commented on COO shares. BNP Paribas Exane raised Cooper Companies from a "neutral" rating to an "outperform" rating and set a $92.00 target price for the company in a research note on Tuesday, July 22nd. Piper Sandler reissued an "overweight" rating and set a $105.00 price target (down from $115.00) on shares of Cooper Companies in a report on Friday, May 30th. Needham & Company LLC raised Cooper Companies from a "hold" rating to a "buy" rating and set a $94.00 target price for the company in a research note on Tuesday, June 17th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $76.00 price target (down from $110.00) on shares of Cooper Companies in a research note on Friday, May 30th. Finally, Mizuho dropped their target price on shares of Cooper Companies from $105.00 to $90.00 and set an "outperform" rating on the stock in a research note on Wednesday, July 16th. Three analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $96.73.

Cooper Companies Stock Up 0.8%

Shares of COO traded up $0.58 during midday trading on Monday, hitting $71.45. The company had a trading volume of 1,416,982 shares, compared to its average volume of 2,354,857. The Cooper Companies, Inc. has a 52 week low of $65.00 and a 52 week high of $112.38. The company's 50 day moving average price is $72.33 and its 200 day moving average price is $80.60. The company has a quick ratio of 1.23, a current ratio of 2.10 and a debt-to-equity ratio of 0.30. The stock has a market cap of $14.29 billion, a price-to-earnings ratio of 34.68, a PEG ratio of 1.73 and a beta of 1.00.

Cooper Companies (NASDAQ:COO - Get Free Report) last announced its earnings results on Thursday, May 29th. The medical device company reported $0.96 earnings per share for the quarter, beating the consensus estimate of $0.93 by $0.03. Cooper Companies had a return on equity of 9.60% and a net margin of 10.39%. The business had revenue of $1 billion during the quarter, compared to analysts' expectations of $995.12 million. During the same quarter last year, the business posted $0.85 earnings per share. The company's quarterly revenue was up 6.3% on a year-over-year basis. On average, equities research analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.